Aphria Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 1,200
Employees
  • Stock Symbol
  • APHA
Stock Symbol
  • Investments
  • 18
  • Share Price
  • $4.93
  • (As of Thursday Closing)

Aphria General Information

Description

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not currently operate in the U.S. due to federal prohibition. The company is focusing on expanding through international cultivation and distribution into the global medical cannabis market. Aphria also offers multiple products under a portfolio of recreational cannabis brands, including Solei, RIFF, and Broken Coast.

Contact Information

Website
Formerly Known As
Black Sparrow Capital
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
TSE
Primary Office
  • PO Box 20009
  • 269 Erie Street South
  • Leamington, Ontario N8H 3C4
  • Canada
+1 (844) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aphria Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.93 $4.87 $1.92 - $7.60 $1.42B 288M 3.3M -$0.25

Aphria Financials Summary

In Thousands,
USD
TTM 31-May-2020 FY 2020 31-May-2020 FY 2019 31-May-2019 FY 2018 31-May-2018
EV 1,126,025 1,126,025 1,632,738 1,497,131
Revenue 404,664 404,664 179,249 29,026
EBITDA (3,805) (3,805) 544 29,502
Net Income (63,149) (63,149) (12,473) 23,154
Total Assets 1,801,235 1,801,235 1,804,576 1,019,095
Total Debt 300,322 300,322 361,118 24,108
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Aphria Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aphria‘s full profile, request access.

Request a free trial

Aphria Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates
Pharmaceuticals
Leamington, Canada
1,200 As of 2020
00000
000000000 00000

00000000

boris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate v
0000000000000
Wakefield, MA
0000 As of 0000
00000
000000000 00000

000000 0

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
00000 000000000000000 000 0000000000000
Smiths Falls, Canada
0000 As of 0000
00000
0.00 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aphria Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Curaleaf Private Equity-Backed Wakefield, MA 0000 00000 000000000 00000
000000 000000 Corporate Backed or Acquired Smiths Falls, Canada 0000 00000 000000&0 00000
0000000 00000000 0 Corporation Toronto, Canada 000 00.000 000000000 00.000
000000 00000 Corporation Toronto, Canada 000 00.000 000000000 00.000
0000000 00000 Corporate Backed or Acquired Burlington, Canada 000.00 000000000 000.00
You’re viewing 5 of 18 competitors. Get the full list »

Aphria Executive Team (11)

Name Title Board Seat Contact Info
Irwin Simon Chief Executive Officer & Chairman
Carl Merton Chief Financial Officer, Finance
James Meiers Chief Operating Officer, Operations
Denise Faltischek Chief Strategy Officer, Strategy
Tim Purdie Chief Information Officer & Executive
You’re viewing 5 of 11 executive team members. Get the full list »

Aphria Board Members (7)

Name Representing Role Since
00000 00000 Aphria Chief Executive Officer & Chairman 000 0000
0000000 0000000 Self Board Member 000 0000
000000 0000 00 Self Board Member 000 0000
You’re viewing 3 of 7 board members. Get the full list »

Aphria Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aphria Investments & Acquisitions (18)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 000000 09-Jan-2019 000000000000000000 000.00 Distributors (Healthcare) 000000 0000000
00000 000-000000 30-Nov-2018 0000 00.000 Drug Discovery 000000 0000000
00000000 00000000 07-Nov-2018 00000 0000000 Cultivation 00000 000000000
00000 00000000 27-Sep-2018 000000000000000000 00000 Holding Companies 000000 0000000
Shöneberg Hospital 17-May-2018 Secondary Transaction - Private 00.000 Hospitals/Inpatient Services 000000 0000000
You’re viewing 5 of 18 investments and acquisitions. Get the full list »

Aphria Subsidiaries (4)

Company Name Industry Location Founded
Althea Company Other Healthcare Services Melbourne, Australia 2017
0000000 Drug Delivery Leamington, Canada 0000
00 000000 Distributors (Healthcare) Densborn, Germany 0000
00000 00000000 Holding Companies Toronto, Canada
To view Aphria’s complete subsidiaries history, request access »

Aphria Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000 000000 16-Apr-2018 0000 00.00 Completed
  • 000000
00 0000000 0000000 24-Oct-2017 00000 00000 00 00.00 Completed
  • 4 buyers
0000000 000000 000 24-May-2017 000000000 0000 Completed
  • 000000
00000000000 00000 27-Mar-2017 000000000 000 Completed
  • 000000
Canabo Medical 07-Dec-2016 PIPE 00.000 Completed
To view Aphria’s complete exits history, request access »